Back to News
Market Impact: 0.2
Baird Partner Alpmed Seeks FDA And EU Clearance For IRE System In Cancer; Stock Plunges 44%
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct Launches
Baird Medical Investment Holdings (BDMD) announced it submitted a 510(k) premarket notification to the FDA and an application for a European CE certificate for a device whose name is truncated in the article. These are regulatory submissions, not announced approvals; the provided text gives no timing, financial figures, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
BDMD0.45
More News
- Binance CFO exits days after catastrophic $6 billion crypto hack
- Paraguay’s ousted president charged over banking scandal
- CoreWeave seeks truce with Texas Governor-elect Hinojosa
- How the US midterm elections reflected resistance to data centres
- Tech companies face mounting child safety lawsuits while pushing AI into schools
- Florida’s new property tax cuts could defund the police, fire fighters and EMS in small towns, threatening ‘rural dark ages,’ former GOP lawmaker says
From AllMind Research
- AllMind Platform Feature Updates - Fall 2026
- AI Credit Covenant Monitoring: From Clause to Review
- AI-Led Expert Interviews vs. Transcript Libraries
- Which AI Investment Research Platforms Are SOC 2 Certified?
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper